“…This evidence gap is compounded by an evidence‐practice gap including the provision of aphasia‐friendly information, support with depression and SLT of adequate intensity to maximise effectiveness (Code & Petheram, 2011; Foster, Worrall, Rose, & O'Halloran, 2015; Hickey, Shrubsole, Worrall, & Power, 2019; Hilari et al., 2015; Rose, Worrall, McKenna, Hickson, & Hoffmann, 2009; Shrubsole, Worrall, & Power, 2019; Shrubsole, Worrall, Power, & O'Connor, 2018; Thomas et al., 2013; Trebilcock et al., 2019). Surveys of SLTs in Australia and Hong Kong highlighted that PWA received sub‐optimum dosage for effective therapy (Kong, 2011; Kong & Tse, 2018; Rose, Ferguson, Power, Togher, & Worrall, 2014; Verna, Davidson, & Rose, 2009). This echoes earlier surveys in Australia, Canada, the United Kingdom and the United States (Katz et al., 2000; Mackenzie et al., 1993; Verna et al., 2009).…”